Certificate of Analysis
Tirzepatide
Values below are transcribed from the signed certificate for each lot, issued by an ISO/IEC 17025 accredited laboratory. Each certificate covers one vial size. They describe the material’s identity and purity only.
20 mg — lot TR20-16-T
| Compound identity | Tirzepatide |
|---|---|
| Variant | Tirzepatide · 20 mg |
| Lot number | TR20-16-T |
| Labeled amount | 20 mg |
| Assayed net peptide | 19.37 mg |
| Purity (HPLC) | > 99.80% |
| Date tested | Oct 6, 2026 |
| Issuing laboratory | Vanguard Laboratory |
| Accreditation | ISO/IEC 17025 (A2LA cert #6377.01.01) |
The signed certificate file for this lot is not posted yet.
30 mg — lot TIR3025
| Compound identity | Tirzepatide |
|---|---|
| Variant | Tirzepatide · 30 mg |
| Lot number | TIR3025 |
| Labeled amount | 30 mg |
| Assayed net peptide | 29.39 mg |
| Purity (HPLC) | > 99.80% |
| Date tested | Dec 19, 2025 |
| Sterility (USP <71>) | No growth detected |
| Bacterial endotoxin (LAL) | < 0.05 EU/mg |
| Heavy metals (ICP-MS) | Screened — Cr, As, Cd, Pb, Hg |
| Issuing laboratory | Vanguard Laboratory |
| Accreditation | ISO/IEC 17025 (A2LA cert #6377.01.01) |
Not yet published for: 10mg, 60mg.
Research use only. Not for human consumption or veterinary use. Sold exclusively to qualified researchers for in vitro and laboratory research. These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Refrigerate upon receipt. Keep in dark environment.
